Nitin Kumar

Nitin Kumar

Auto-generated profile, based on publicly available information

Nitin Kumar

Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, UK

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2020 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
KJKylie Renee James
Kylie Renee James
TGTomas Gomes
Tomas Gomes
RERasa Elmentaite
Rasa Elmentaite
NKNitin Kumar
Nitin Kumar
EGEmily L. Gulliver
Emily L. Gulliver
STSarah A. Teichmann
Sarah A. Teichmann

1 February 2018 in Gastroenterology
Verified
Journal Article
Open access
KHKate Joanne Howell
Kate Joanne Howell
JKJudith Kraiczy
Judith Kraiczy
KNKomal M. Nayak
Komal M. Nayak
MGMarco Gasparetto
Marco Gasparetto
ARAlexander Ross
Alexander Ross
MZMatthias Zilbauer
Matthias Zilbauer
We analyzed DNA methylation patterns and transcriptomes of primary intestinal epithelial cells (IEC) of children newly diagnosed with inflammatory bowel diseases (IBD) to learn more about pathogenesis. We obtained mucosal biopsies (N = 236) collected from terminal ileum and ascending and sigmoid colons of children (median age 13 years) newly diagnosed with IBD (43 with Crohn's disease [CD], 23 with ulcerative colitis [UC]), and 30 children without IBD (controls). Patients were recruited and managed at a hospital in the United Kingdom from 2013 through 2016. We also obtained biopsies collected at later stages from a subset of patients. IECs were purified and analyzed for genome-wide DNA methylation patterns and gene expression profiles. Adjacent microbiota were isolated from biopsies and analyzed by 16S gene sequencing. We generated intestinal organoid cultures from a subset of samples and genome-wide DNA methylation analysis was performed. We found gut segment-specific differences in DNA methylation and transcription profiles of IECs from children with IBD vs controls; some were independent of mucosal inflammation. Changes in gut microbiota between IBD and control groups were not as large and were difficult to assess because of large amounts of intra-individual variation. Only IECs from patients with CD had changes in DNA methylation and transcription patterns in terminal ileum epithelium, compared with controls. Colon epithelium from patients with CD and from patients with ulcerative colitis had distinct changes in DNA methylation and transcription patterns, compared with controls. In IECs from patients with IBD, changes in DNA methylation, compared with controls, were stable over time and were partially retained in ex-vivo organoid cultures. Statistical analyses of epithelial cell profiles allowed us to distinguish children with CD or UC from controls; profiles correlated with disease outcome parameters, such as the requirement for treatment with biologic agents. We identified specific changes in DNA methylation and transcriptome patterns in IECs from pediatric patients with IBD compared with controls. These data indicate that IECs undergo changes during IBD development and could be involved in pathogenesis. Further analyses of primary IECs from patients with IBD could improve our understanding of the large variations in disease progression and outcomes.

4 November 2020 in Nature
Verified
Journal Article
Closed access
PDF file
ZFZachary Fitzpatrick
Zachary Fitzpatrick
GFGordon Frazer
Gordon Frazer
AFAshley Ferro
Ashley Ferro
SCSimon Clare
Simon Clare
NBNicolas Bouladoux
Nicolas Bouladoux
MCMenna R. Clatworthy
Menna R. Clatworthy

17 March 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
SFSamuel Forster
Samuel Forster
JLJunyan Liu
Junyan Liu
NKNitin Kumar
Nitin Kumar
EGEmily L. Gulliver
Emily L. Gulliver
JGJodee A. Gould
Jodee A. Gould
TLTrevor D. Lawley
Trevor D. Lawley
Mobile genetic elements (MGEs) carrying antibiotic resistance genes (ARGs) disseminate ARGs when they mobilise into new bacterial hosts. The nature of such horizontal gene transfer (HGT) events between human gut commensals and pathogens remain poorly characterised. Here, we compare 1354 cultured commensal strains (540 species) to 45,403 pathogen strains (12 species) and find 64,188 MGE-mediated ARG transfer events between the two groups using established methods. Among the 5931 MGEs, we find 15 broad host range elements predicted to have crossed different bacterial phyla while also occurring in animal and environmental microbiomes. We experimentally demonstrate that predicted broad host range MGEs can mobilise from commensals Dorea longicatena and Hungatella hathewayi to pathogen Klebsiella oxytoca, crossing phyla simultaneously. Our work establishes the MGE-mediated ARG dissemination network between human gut commensals and pathogens and highlights broad host range MGEs as targets for future ARG dissemination management.

1 September 2016 in New Microbes and New Infections
Verified
Journal Article
Open access
CSCheshta Sharma
Cheshta Sharma
NKN. Kumar
N. Kumar
RPR. Pandey
R. Pandey
JMJ.F. Meis
J.F. Meis
ACAnuradha Chowdhary
Anuradha Chowdhary
Candida auris is an emerging multidrug resistant yeast that causes nosocomial fungaemia and deep-seated infections. Notably, the emergence of this yeast is alarming as it exhibits resistance to azoles, amphotericin B and caspofungin, which may lead to clinical failure in patients. The multigene phylogeny and amplified fragment length polymorphism typing methods report the C. auris population as clonal. Here, using whole genome sequencing analysis, we decipher for the first time that C. auris strains from four Indian hospitals were highly related, suggesting clonal transmission. Further, all C. auris isolates originated from cases of fungaemia and were resistant to fluconazole (MIC >64 mg/L).

1 April 2022 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
SFSamuel Forster
Samuel Forster
SCSimon Clare
Simon Clare
BBBenjamin S. Beresford-Jones
Benjamin S. Beresford-Jones
KHKatherine Harcourt
Katherine Harcourt
GNGeorge Notley
George Notley
TLTrevor D. Lawley
Trevor D. Lawley
Experimental mouse models are central to basic biomedical research; however, variability exists across genetically identical mice and mouse facilities making comparisons difficult. Whether specific indigenous gut bacteria drive immunophenotypic variability in mouse models of human disease remains poorly understood. We performed a large-scale experiment using 579 genetically identical laboratory mice from a single animal facility, designed to identify the causes of disease variability in the widely used dextran sulphate sodium mouse model of inflammatory bowel disease. Commonly used treatment endpoint measures—weight loss and intestinal pathology—showed limited correlation and varied across mouse lineages. Analysis of the gut microbiome, coupled with machine learning and targeted anaerobic culturing, identified and isolated two previously undescribed species, Duncaniella muricolitica and Alistipes okayasuensis, and demonstrated that they exert dominant effects in the dextran sulphate sodium model leading to variable treatment endpoint measures. We show that the identified gut microbial species are common, but not ubiquitous, in mouse facilities around the world, and suggest that researchers monitor for these species to provide experimental design opportunities for improved mouse models of human intestinal diseases.